Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Leadership & Expert Views - Cancer Currents Blog

Commentaries from scientific leaders at NCI and other institutions about cancer research topics, programs, and initiatives.

  • CT scan showing a cross-section of the chest with a large white mass in the left lung, indicating a tumor.
    • By Stephanie R. Land, Ph.D.

    NCI has released a new funding announcement to stimulate research on optimal smoking cessation approaches delivered in conjunction with lung cancer screening.

  • Photo of Warren Kibbe
    • By Warren Kibbe, Ph.D.

    The enhanced clinical trials search function on Cancer.gov will allow users to more easily find accurate and timely information about active and recruiting NCI-supported clinical trials.

  • Dr. Lowy speaks from an AACR lectern
    • By Douglas Lowy, M.D.

    Yesterday, at the AACR annual meeting, Dr. Doug Lowy spoke directly to the research community about his goals as NCI Acting Director. Dr. Lowy said that he plans to continue many of the programs launched by his predecessor, Dr. Harold Varmus, and to sharpen the institute’s focus in several areas where he believes greater progress can offer significant dividends.

  • A puzzle diagram titled “Cancer Surveillance: What do we need to collect”? In the center, a piece is labeled “Cancer Patient”; the other puzzles are various types of treatments.
    • By NCI Staff

    Since the early 1970s, NCI’s SEER program has been an invaluable resource for statistics on cancer in the United States. For the past several years, SEER researchers have been working toward a much broader and comprehensive goal for providing cancer statistics on a nationwide basis.

  • Headshot of Bob Croyle
    • By Robert Croyle, Ph.D.

    A more substantial and coordinated effort is needed to advance the science of cancer care delivery to help address the complex problems facing our health care systems. In response, NCI has created a new Healthcare Delivery Research Program (HDRP) to strengthen its support and coordination of research in ways that both improve survival and enhance patient care experiences.

  • Frank McCormick, Ph.D.
    • By NCI Staff

    Frank McCormick, Ph.D., talks about the history, the challenges, and the future of research on RAS gene mutations, which drive more than 30 percent of all human cancers.

  • ""
    • By Douglas Lowy, M.D.

    Doug Lowy, M.D., a long-time researcher and leader at NCI, greets the cancer research community as the institute's new acting director.

  • Headshot of Barry Kramer
    • By Barry Kramer, M.D., M.P.H.

    Barry Kramer, M.D., M.P.H., talks about NCI's efforts for improving cancer prevention and early detection, two topics discussed in the documentary film, Cancer: The Emperor of All Maladies.

  • Headshot of Malcolm A. Smith
    • By Malcolm A. Smith, M.D., Ph.D.

    NCI’s Dr. Malcolm Smith discusses future directions of childhood cancer research, including treatment directions and clinical trials.

  • Photo of Peter Garrett
    • By Peter Garrett

    Peter Garrett, acting director of NCI's communications office, discusses the Annual Report to the Nation on the Status of Cancer and activities surrounding the broadcast of the documentary film, Cancer: The Emperor of All Maladies.

< Older Posts Newer Posts >
Email